Evidence map›Paper›PMID 41429566›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2026

Association of neurodevelopmental conditions with Alzheimer's disease and related dementias and Parkinson's disease.

Jessica E Rast, Andrea L Rosso, Bryan D James, Jack F G Underwood, Jacob Bergstedt, Viktor H Ahlqvist, Jakob Grove, Fang Fang, Neal D Goldstein, Giacomo Vivanti and 10 more

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jessica E RastA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, United States.ORCID 0000-0002-1381-130X
Andrea L RossoSchool of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Bryan D JamesRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States.ORCID 0000-0003-1932-151X
Jack F G UnderwoodNeuroscience and Mental Health Innovation Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0003-1731-6039
Jacob BergstedtUnit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Viktor H AhlqvistUnit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Jakob GroveDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Fang FangUnit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3310-6456
Neal D GoldsteinDepartment of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, United States.
Giacomo VivantiA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, United States.
Stephen Z LevineSchool of Public Health, University of Haifa, Haifa, Israel.ORCID 0000-0002-5544-0420
Anna NordströmSchool of Sport Sciences, UiT the Arctic University of Norway, Tromsø, Norway.ORCID 0000-0003-3534-456X
Diana SchendelA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, United States.
Kristen LyallA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, United States.
Peter NordströmDepartment of Public Health and Caring Sciences, Clinical Geriatrics, Uppsala University, Uppsala, Sweden.
Marcel BallinDepartment of Public Health and Caring Sciences, Clinical Geriatrics, Uppsala University, Uppsala, Sweden.
Jean StaffordCollege of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Adam C NajDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Brian K LeeA.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, United States.
LEGENNDS Consortium

Funding

LEGENNDS: Linking Epidemiology and GEnetics of Neurodevelopmental and Neurodegenerative Disorders StudyR01NS131433 · NINDS · DREXEL UNIVERSITY · PI Brian Kane Lee · 2023 to 2026
$2.1M
Alzheimer's Society FellowshipNIH HHS R01NS131433NINDS NIH HHS R01 NS131433
6 · The paper itself

Abstract

backgroundNeurodevelopmental conditions (NDC), including attention deficit/hyperactivity disorder (ADHD) and autism, are associated with increased rates of neurodegenerative diseases, including Alzheimer's disease and related dementias (ADRD) and Parkinson's disease. Such associations are unstudied in diverse populations and while controlling for a range of important covariates. The purpose of this study was to examine the association of ADRD and Parkinson's disease with NDCs in a diverse sample of adults.

methodsThis case-control study used data from the United States All of Us Research Program 2018-2023 from approximately 600 000 adults in the United States. We matched on ADRD and Parkinson's disease status to examine the association of these conditions with NDCs.

resultsNDC was more prevalent in ADRD cases than in non-ADRD controls (7.8% vs 2.4%) and among Parkinson's disease cases than non-Parkinson's disease controls (4.5% vs 1.8%). After adjustment for sex, age, education level, body mass index, cardiometabolic conditions, and psychiatric conditions, individuals with ADRD had significantly higher odds of having an NDC compared with controls (adjusted odds ratio, 2.68; 95% CI, 2.40-2.99). Similarly, Parkinson's disease cases had 2.09 times the odds of having an NDC as non-Parkinson's disease controls (95% CI 1.66, 2.59) in adjusted models.

conclusionsAs the population of individuals with NDCs ages, and more older adults find themselves in the care of clinicians with expertise in ADRD and Parkinson's disease, it is imperative to understand the support needs of this population, and to provide targets for reducing ADRD prevalence in younger or middle adulthood.

Indexed as

Alzheimer DiseaseDementiaNeurodevelopmental DisordersParkinson DiseaseAdultAgedAged, 80 and overCase-Control StudiesFemaleHumansMaleMiddle AgedPrevalenceUnited StatesAll of UsAttention deficit/hyperactivity disorderAutismElectronic health record

Identifiers

PMID41429566
PMCPMC13016892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.